Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04905134 · ClinicalTrials.gov registry record · NA

Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings - Optimization Phase

A NA study of Head and Neck Cancer and Oral Cancer, sponsored by Duke University.

Completed
Registry status
NA
Development phase
53
Enrollment target
1
Study location

NCT04905134 is a NA study of Head and Neck Cancer and Oral Cancer that has completed, run by Duke University. The registered enrollment target is 53 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04905134, a NA study of Head and Neck Cancer and Oral Cancer, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

This study aims to develop and evaluate a low-cost, portable, flexible nasopharyngeal scope (FNS) used to assess head and neck cancers (HNC) in low resource settings. The FNS will be compared to an endoscope that is used as standard of care (SOC) in terms of ease of use, image quality, and perceived pain. The ultimate goal is to compare the ease of use between the FNS to what is used in SOC.

Interventions

  • DEVICE Nasopharyngoscope

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2023-07-31
Est. Completion 2023-09-22
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT04905134

The ClinicalTrials.gov registry entry for NCT04905134 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (80% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which Nasopharyngoscope is the first listed.

NCT04905134 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04905134 about?

NCT04905134 is a clinical study titled "Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings - Optimization Phase". This study aims to develop and evaluate a low-cost, portable, flexible nasopharyngeal scope (FNS) used to assess head and neck cancers (HNC) in low resource settings. The FNS will be compared to an endoscope that is used as standard of care (SOC) in terms of ease of use, image quality, and perceived...

What is the current status of trial NCT04905134?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2023-07-31. Estimated completion is 2023-09-22.

What conditions does trial NCT04905134 study?

This clinical trial studies the following conditions: Head and Neck Cancer, Oral Cancer.

What interventions are being tested in trial NCT04905134?

The interventions under investigation include: Nasopharyngoscope (DEVICE).

Who is sponsoring clinical trial NCT04905134?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04905134 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.